[1] ELMORE LW,GREER SF,DANIELS EC,et al.Blueprint for cancer research:Critical gaps and opportunities［J］.CA Cancer J Clin,2021,71(2):107-139.
[2] NOGUEIRA LM,YABROFF KR,BERNSTEIN A.Climate change and cancer［J］.CA Cancer J Clin,2020,70(4):239-244.
[3] LIND AL,POLLARD KS.The gut microbiomes of 180 species［J］.Science,2021,372(6539):238-239.
[4] GOECKS J,JALILI V,HEISER LM,et al.How machine learning will transform biomedicine［J］.Cell,2020,181(1):92-101.
[5] DOSSETT ML,FRICCHIONE GL,BENSON H,et al.A new era for mind-body medicine［J］.N Engl J Med,2020,382(15):1390-1391.
[6] ATANASOV AG,ZOTCHEV SB,DIRSCH VM,et al.Natural products in drug discovery:advances and opportunities［J］.Nat Rev Drug Discov,2021,20(3):200-216.
[7] CLARKE MA,FISHER J.Executable cancer models:successes and challenges［J］.Nat Rev Cancer,2020,20(6):343-354.
[8] SHENDURE J,FINDLAY GM,SNYDER MW.Genomic medicine-progress,pitfalls,and promise［J］.Cell,2019,177(1):45-57.
[9] SAHA K,SONTHEIMER EJ,BROOKS PJ,et al.The NIH somatic cell genome editing program［J］.Nature,2021,592(7853):195-204.
[10] CHAKRAVARTY D,SOLIT DB.Clinical cancer genomic profiling［J］.Nat Rev Genet,2021,22(8):483-501.
[11] RODRIGUEZ H,ZENKLUSEN JC,STAUDT LM,et al.The next horizon in precision oncology:Proteogenomics to inform cancer diagnosis and treatment［J］.Cell,2021,184(7):1661-1670.
[12] OH ES,PETRONIS A.Origins of human disease:the chrono-epigenetic perspective［J］.Nat Rev Genet,2021,22(8):533-546.
[13] TACHIBANA C.Beyond CRISPR:What' s current and upcoming in genome editing［J］.Science,2019,365(6460):1481-1483.
[14] NATH A,BILD AH.Leveraging single-cell approaches in cancer precision medicine［J］.Trends Cancer,2021,7(4):359-372.
[15] DENNY JC,COLLINS FS.Precision medicine in 2030-seven ways to transform healthcare［J］.Cell,2021,184(6):1415-1419.
[16] CHENG ML,PECTASIDES E,HANNA GJ,et al.Circulating tumor DNA in advanced solid tumors:Clinical relevance and future directions［J］.CA Cancer J Clin,2021,71(2):176-190.
[17] RAJKOMAR A,DEAN J,KOHANE I.Machine learning in medicine［J］.N Engl J Med,2019,380(14):1347-1358.
[18] ALLADA R,BASS J.Circadian mechanisms in medicine［J］.N Engl J Med,2021,384(6):550-561.
[19] SANCAR A,VAN GRN.Clocks,cancer,and chronochemotherapy［J］.Science,2021,371(6524):eabb0738.
[20] GUO P,HUANG J,MOSES MA.Cancer nanomedicines in an evolving oncology landscape［J］.Trends Pharmacol Sci,2020,41(10):730-742.
[21] MARTIN JD,CABRAL H,STYLIANOPOULOS T,et al.Improving cancer immunotherapy using nanomedicines:progress,opportunities and challenges［J］.Nat Rev Clin Oncol,2020,17(4):251-266.
[22] ROTTENBERG S,DISLER C,PEREGO P.The rediscovery of platinum-based cancer therapy［J］.Nat Rev Cancer,2021,21(1):37-50.
[23] CAMMAROTA G,IANIRO G,AHERN A,et al.Gut microbiome,big data and machine learning to promote precision medicine for cancer［J］.Nat Rev Gastroenterol Hepatol,2020,17(10):635-648.
[24] HEY SP,GERLACH CV,DUNLAP G,et al.The evidence landscape in precision medicine［J］.Sci Transl Med,2020,12(540):eaaw7745.
[25] THOMAS PS,SILVA BC,BARTO AG,et al.Preventing undesirable behavior of intelligent machines［J］.Science,2019,366(6468):999-1004.
[26] MAKIN S.The emerging world of digital therapeutics［J］.Nature,2019,573(7775):S106-S109.
[27] XU S,JAYARAMAN A,ROGERS JA.Skin sensors are the future of health care［J］.Nature,2019,571(7765):319-321.
[28] SIM I.Mobile devices and health［J］.N Engl J Med,2019,381:956-968.
[29] MADHAVAN S,BECKMAN RA,MCCOY MD,et al.Envisioning the future of precision oncology trials［J］.Nature Cancer,2021,2:9-11.
[30] RAJEWSKY N,ALMOUZNI G,GORSKI SA,et al.LifeTime and improving European healthcare through cell-based interceptive medicine［J］.Nature,2020,587(7834):377-386.
[31] TOPOL EJ.High-performance medicine:The convergence of human and artificial Intelligence［J］.Nat Med,2019,25(1):44-56.
[32] BERA K,SCHALPER KA,RIMM DL,et al.Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology［J］.Nat Rev Clin Oncol,2019,16(11):703-715.
[33] ZHAVORONKOV A,BISCHOF E,LEE KF.Artificial intelligence in longevity medicine［J］.Nature Aging,2021,1:5-7.
[34] MARKS P,GOTTLIEB S.Balancing safety and innovation for cell-based regenerative medicine［J］.N Engl J Med,2018,378(10):954-959.
[35] KIM J,KOO BK,KNOBLICH JA.Human organoids:model systems for human biology and medicine［J］.Nat Rev Mol Cell Biol,2020,21(10):571-584.
[36] TAN X,LETENDRE JH,COLLINS JJ,et al.Synthetic biology in the clinic:engineering vaccines,diagnostics,and therapeutics［J］.Cell,2021,184(4):881-898.
[37] SALAZAR-CAVAZOS E,ALTAN-BONNET G.Engineering time-controlled immunotherapy［J］.Science,2022,378(6625):1175-1176.
[38] TAO F,QI Q.Make more digital twins［J］.Nature,2019,573(7775):490-491.
[39] JIANG P,SINHA S,ALDAPE K,et al.Big data in basic and translational cancer research［J］.Nat Rev Cancer,2022,22(11):625-639.